SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-032702
Filing Date
2020-10-22
Accepted
2020-10-22 08:36:32
Documents
5
Period of Report
2020-10-21
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea128751-8k_avalonglobo.htm 8-K 21433
2 DISTRIBUTION AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND AVALON GLOBOCARE ea128751ex99-1_avalonglobo.htm EX-99.1 33653
3 DISTRIBUTION AGREEMENT BETWEEN ADIAL PHARMACEUTICALS, INC. AND AVALON GLOBOCARE ea128751_ex99-2avalonglobo.htm EX-99.2 15172
4 GRAPHIC image_001.jpg GRAPHIC 9684
5 GRAPHIC image_002.jpg GRAPHIC 5468
  Complete submission text file 0001213900-20-032702.txt   92704
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 (646) 762-4517
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 201251780
SIC: 8742 Services-Management Consulting Services